Prevalence of Renal Cell Carcinoma in Patients With Autosomal Dominant Polycystic Kidney Disease and Chronic Renal Failure

被引:93
作者
Hajj, Pascal [1 ]
Ferlicot, Sophie
Massoud, Walid
Awad, Ayman
Hammoudi, Yacine
Charpentier, Bernard
Durrbach, Antoine
Droupy, Stephane
Benoit, Grard
机构
[1] Univ Paris Sud, Bicetre Univ Hosp, Dept Urol, F-94270 Le Kremlin Bicetre, France
关键词
LAPAROSCOPIC NEPHRECTOMY; TRANSPLANT RECIPIENTS; ALLOGRAFT; DIALYSIS; TUMORS;
D O I
10.1016/j.urology.2009.02.078
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
100201 [内科学]; 100221 [泌尿外科学];
摘要
OBJECTIVES To study the prevalence and the characteristics of renal cell carcinoma (RCC) in patients with autosomal dominant polycystic kidney disease (ADPKD) in Our series. METHODS We reviewed retrospectively all the nephrectomies performed in our department between 1982 and 2003 in patients with ADPKD and chronic renal failure. RESULTS Seventy-nine patients (42 males and 37 females) with ADPKD and chronic renal failure underwent 89 nephrectomies; in 10 of 79, both kidneys were removed but not simultaneously. Mean age was 50.4 years (range, 32-69 years). Of 79 patients, 50 had end-stage renal disease (ESRD) and were on hemodialysis or had received a transplant for >1 year. On histologic examination, 11 of 89 kidneys were diagnosed with carcinomas. There was I patient with bilateral tumor (tubulopapillary Ca) and 3 kidneys (27.3%) with multifocal tumors. Regarding the histologic type, there were 7 of 12 (58.3%) clear cell carcinomas and the remaining 5 (41.7%) were tubulopapillary carcinomas. CONCLUSIONS The prevalence of RCC was higher in patients with ADPKD and ESRD, with >1 year on dialysis or renal transplantation undergoing nephrectomy according the protocol. It would be 2 to 3 times more frequent than RCC in patients with ESRD alone. The clinician should maintain a high alert of suspicion for RCC in such patients. UROLOGY 74: 631-634, 2009. (C) 2009 Elsevier Inc.
引用
收藏
页码:631 / 634
页数:4
相关论文
共 29 条
[1]
POLYCYSTIC RENAL-DISEASE [J].
ANDERSON, GA ;
DEGROOT, D ;
LAWSON, RK .
UROLOGY, 1993, 42 (04) :358-364
[2]
Cancer incidence and mortality in the European Union: Cancer registry data and estimates of national incidence for 1990 [J].
Black, RJ ;
Bray, F ;
Ferlay, J ;
Parkin, DM .
EUROPEAN JOURNAL OF CANCER, 1997, 33 (07) :1075-1107
[3]
Chang Yu-Lung, 2007, J Chin Med Assoc, V70, P403, DOI 10.1016/S1726-4901(08)70029-7
[4]
Coulange C, 1995, Prog Urol, V5, P529
[5]
Multicentric papillary renal carcinoma in renal allograft [J].
DeLong, MJ ;
Schmitt, D ;
Scott, KM ;
Ramakumar, S ;
Lien, YHH .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 42 (02) :381-384
[6]
Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation: A pathologic analysis [J].
Denton, MD ;
Magee, CC ;
Ovuworie, C ;
Mauiyyedi, S ;
Pascual, M ;
Colvin, RB ;
Cosimi, AB ;
Tolkoff-Rubin, N .
KIDNEY INTERNATIONAL, 2002, 61 (06) :2201-2209
[7]
Laparoscopic nephrectomy in patients with end-stage renal disease and autosomal dominant polycystic kidney disease [J].
Dunn, MD ;
Portis, AJ ;
Elbahnasy, AM ;
Shalhav, AL ;
Rothstein, M ;
McDougall, EM ;
Clayman, RV .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (04) :720-725
[8]
Gamé X, 2003, PROG UROL, V13, P215
[9]
RENAL-CELL CARCINOMA IN AN ALLOGRAFT KIDNEY-TRANSPLANT [J].
HEINZPEER, G ;
HELBICH, T ;
NOTTLING, B ;
KLAUSER, R ;
MUHLBACHER, F ;
HUBSCH, P .
TRANSPLANTATION, 1994, 57 (03) :475-478
[10]
RENAL-TRANSPLANTATION FOR END-STAGE POLYCYSTIC KIDNEY-DISEASE [J].
HOHSIEH, H ;
NOVICK, AC ;
STEINMULLER, D ;
STREEM, SB ;
BUSZTA, C ;
GOORMASTIC, M .
UROLOGY, 1987, 30 (04) :322-326